跳至主要内容
临床试验/NCT00488007
NCT00488007已完成不适用

Clinical Trial on Cognitive, Behavioural, Quality of Life and Medico-economic Benefits of Hearing Aids in Alzheimer Disease Patients Suffering From Presbycusis

Hospices Civils de Lyon2 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2007年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
51
试验地点
2
主要终点
Cognitive benefit evaluated thanks to the ADAS-Cog scale

研究概览

简要总结

This is a 12-months' randomized clinical trial that aims at studying the benefit of bilateral hearing aids in hearing impaired patients suffering from a slight to moderate stage Alzheimer disease.

The benefit of this intervention will be studied in the cognitive, behavioural, quality of life and economic fields.

2groups are involved in this trial: Intervention group: 12 months' treatment with active hearing aids, fitted hearing impairment Control group: 6 months' treatment with placebo hearing aids, followed with 6 months' active hearing aids, fitted hearing impairment

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • > 65 year-old
  • Medical diagnosis of Alzheimer disease
  • 15 ≤ MMSE ≤ 25
  • No hearing aids in the last 2 years
  • Motivated caregiver living with the patient
  • Sensorineural hearing loss

排除标准

  • Beginning of an anticholinesterasic treatment in the last 6 months
  • Change in the anticholinesterasic treatment in the last 2 months

结局指标

主要结局

Cognitive benefit evaluated thanks to the ADAS-Cog scale

时间窗: Times of measurements: 0, 6th and 12th month

次要结局

  • Quality of life scales: Zarit scale and ADRQL(Zarit scale(every 2 months during the study time), ADRQL (0, 6th and 12th month))
  • Consumption questionnaire(monthly)
  • Cognitive scales: MMSE, Grober and Buschke, Digit symbol test(0, 6th and 12th month)
  • Behavioural scales: IADL, NPI(1st week, 3rd 6th 9th and 12th month)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验